Comera Life Sciences Holdings, Inc.

12 Gill Street, Suite 4650

Woburn, Massachusetts 01801

September 13, 2022

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Re: Comera Life Sciences Holdings, Inc.

Registration Statement on Form S-1

File No. 333-267283

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Comera Life Sciences Holdings, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-267283) so that it may become effective at 4:00 p.m. Eastern time on September 15, 2022, or as soon thereafter as practicable.

[Remainder of this page intentionally left blank]

Very truly yours,
Comera Life Sciences Holdings, Inc.
By:	/s/ Jeffrey S. Hackman
Name:	Jeffrey S. Hackman
Title:	Chairman, President and CEO